🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Material Elimination

Based on the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the service safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.

Within moments of entering one group, a seller shared contact information, where most purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, messages show dark colored parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly serious health risks”.